ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P 500
5,266.95
-0.74%
US Tech 100
18,210.00
-0.96%
Dow Jones
38,441.54
-1.06%
Brent Oil
83.375
-1.13%
Bitcoin
67,550.02
-1.09%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Tango Therapeutics Inc (TNGX) Quote

Tango Therapeutics Inc

Tango Therapeutics Inc (TNGX)

NASDAQ
6.75
-0.10
(-1.46%)
At close: May 29 4:00PM
Delayed by 15 minutes
6.75
-0.10
( -1.46% )
After Hours: 4:07PM
Delayed by 15 minutes

Professional-Grade Tools, for Individual Investors.

Premium

Key stats and details

Current Price
6.75
Bid
6.55
Ask
10.83
Volume
638,243
6.48 Day's Range 6.79
2.47 52 Week Range 13.03
Market Cap
688.43M
Previous Close
6.85
Open
6.72
Last Trade
1242
@
6.75
(priorref)
Last Trade Time
16:02:23
Financial Volume
$ 4,271,325
VWAP
6.6923
Average Volume (3m)
617,950
Shares Outstanding
101,989,696
Dividend Yield
-
PE Ratio
-6.77
Earnings Per Share (EPS)
-1
Revenue
36.53M
Net Profit
-101.74M

About Tango Therapeutics Inc

Tango Therapeutics Inc is a biotechnology company. It is dedicated towards discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. Tango Therapeutics Inc is a biotechnology company. It is dedicated towards discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer.

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
www.tangotx.com
Headquarters
Wilmington, Delaware, USA
Founded
1970
Tango Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker TNGX. The last closing price for Tango Therapeutics was $6.85. Over the last year, Tango Therapeutics shares have traded in a share price range of $ 2.47 to $ 13.03.

Tango Therapeutics currently has 101,989,696 shares outstanding. The market capitalization of Tango Therapeutics is $688.43 million. Tango Therapeutics has a price to earnings ratio (PE ratio) of -6.77.

TNGX Latest News

More News

Medivir´s licensee, Tango Therapeutics, has discontinued development of its TNG348 clinical program

Medivir´s licensee, Tango Therapeutics, has discontinued development of its TNG348 clinical program PR Newswire STOCKHOLM, May 23, 2024 STOCKHOLM, May 23, 2024 /PRNewswire/ -- Medivir AB (Nasdaq...

May 23 2024
PR Newswire (US)

Form 8-K - Current report

May 23 2024
Edgar (US Regulatory)

Tango Therapeutics Announces Discontinuation of TNG348 Program

– The phase 1/2 clinical trial of TNG348, a USP1 inhibitor, is being terminated due to toxicity observed in the initial study cohorts – – Cash runway extended into 2027, PRMT5 and CoREST clinical...

May 23 2024
Business Wire

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

May 08 2024
Edgar (US Regulatory)

Form 8-K - Current report

May 08 2024
Edgar (US Regulatory)

Tango Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Highlights

– Dose expansion initiated in TNG908 phase 1/2 clinical trial – – Dose expansion expected to initiate in TNG462 phase 1/2 clinical trial in 2Q 2024 – – Clinical data expected in 2H 2024 from...

May 08 2024
Business Wire

Tango Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Tango Therapeutics, Inc. (NASDAQ: TNGX), a clinical-stage biotechnology company committed to discovering and delivering the next generation of precision cancer medicines, today announced that...

April 01 2024
Business Wire

Tango Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Highlights

– Dose escalation ongoing in four clinical-stage precision oncology programs; TNG908 phase 1/2 clinical data expected in 2024 – – First patient dosed in phase 1/2 clinical trial of TNG348 in...

March 18 2024
Business Wire
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.68-9.152086137287.437.696.486644037.05269793CS
4-0.76-10.1198402137.518.386.485414457.4672625CS
12-4.77-41.4062511.5211.716.486179508.06370503CS
26-0.77-10.23936170217.5213.0056.486206529.48220072CS
523.73123.5099337753.0213.032.4710418528.28949878CS
156-2.86-29.76066597299.6118.842.475199468.02209468CS
260-2.86-29.76066597299.6118.842.475199468.02209468CS

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
KTRAKintara Therapeutics Inc
$ 0.3883
(42.76%)
17.99M
ONMDOneMedNet Corporation
$ 2.76
(41.54%)
4.71M
SPGCSacks Parente Golf Inc
$ 0.78
(30.22%)
3.99M
RRGBRed Robin Gourmet Burgers Inc
$ 7.61
(13.08%)
53.84k
KZIAKazia Therapeutics Ltd
$ 0.2691
(11.20%)
3.51k
ONCOOnconetix Inc
$ 0.25
(-15.23%)
2.31M
FFIEFaraday Future Intelligent Electric Inc
$ 0.3778
(-14.95%)
24.55M
GVHGlobavend Holdings Ltd
$ 1.25
(-12.59%)
68.5k
SNOASonoma Pharmaceuticals Inc
$ 0.2279
(-12.35%)
2.55M
STSSSharps Technology Inc
$ 0.40
(-11.82%)
252.81k
GWAVGreenwave Technology Solutions Inc
$ 0.053
(7.29%)
66.26M
FFIEFaraday Future Intelligent Electric Inc
$ 0.3778
(-14.95%)
24.55M
KTRAKintara Therapeutics Inc
$ 0.3883
(42.76%)
17.99M
LUCYInnovative Eyewear Inc
$ 0.93
(-2.00%)
9.18M
VERBVerb Technology Company Inc
$ 0.155
(-3.85%)
8.06M

TNGX Discussion

View Posts
Monksdream Monksdream 4 weeks ago
TNGX under $10
👍️0
bikaver bikaver 8 months ago
Stopped out with small loss.
👍️0
bikaver bikaver 9 months ago
TNGX......Holding up well, but will tumble soon.
👍️0
bikaver bikaver 10 months ago
TNGA.....short @ 8.60 This is the strength that I wanted to see!
👍️0
bikaver bikaver 10 months ago
TNGX.....Studying the TNGX chart this evening. I'll short it at a good sign of strength if the opportunity presents itself tomorrow.
👍️0
SmokeSignals SmokeSignals 10 months ago
up $4>H.C. Wainwright Reaffirms Their Buy Rating on Tango Therapeutics (TNGX)AUGUST 8, 2023TIPRANKS
Barclays Releases a Buy Rating on Tango Therapeutics (TNGX)AUGUST 8, 2023TIPRANKS
Goldman Sachs Keeps Their Buy Rating on Tango Therapeutics (TNGX)AUGUST 7, 2023TIPRANKS
Tango Therapeutics Reports Second Quarter 2023 Financial Results and Provides Business HighlightsAUGUST 7, 2023TIPRANKS
Tango Therapeutics reports Q2 EPS (23c), consensus (34c)AUGUST 7, 2023TIPRANKS
👍️0

Your Recent History

NASDAQ
TNGX
Tango Therapeutics
BOV
RSID3
ROSSI RESID ON
USOTC
GTMUF
Giant Manufacture (PK)
BOV
RCSL4
RECRUSUL PN
BIT
I08643
Intesa Sanpaolo
LSE
FE86
Hsbc Bk.28
EU
MLUMG
Umalis
USOTC
UBSNF
UBS ETF (GM)
BIT
SEB
Sebino
BMF
FROJ27
FROJ27 - 04/2027
BIT
P18VV7
BNP Paribas Issuance
NASDAQ
RBGIX
RBC Small Cap Growth Fun...
ASX
AQXOA
Alice Queen
BIT
P1DDA9
BNP Paribas Issuance
ASX
KLR
Kaili Resources
EU
Q242S
Q242S
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved